Company: BDRX
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001214659-25-007913
Chunk: 4

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-15
Form: 424B3
Chunk 4
---
 otherwise cause the Holder to exceed the beneficial ownership limitations
set forth in Section 2(e) of the applicable Warrants, upon notice from the Holder of such limitation the Company shall only issue such
number of Warrant Shares to the Holder that would not cause the Holder to exceed the maximum number of Warrant Shares permitted thereunder
with the balance to be held in abeyance until notice from the Holder that the balance (or portion thereof) may be issued in compliance
with such limitations, which abeyance shall be evidenced through the applicable Warrant which shall be deemed prepaid thereafter, and
exercised pursuant to a Notice of Exercise in the applicable Warrant (provided no additional exercise price shall be payable).

If the Holder accepts this
offer by countersigning this letter below, the Holder hereby irrevocably and unconditionally covenants and agrees that it shall (i) not
sell or transfer such Warrant Shares until after May 22, 2025, after which time the Holder shall be free to sell or transfer such Warrant
Shares, and (ii) to the extent the Company calls a General Meeting of Shareholders and/or Annual General Meeting of Shareholders during
the period the Holder is the beneficial and/or record owner of such Warrant Shares, (x) cause to be counted for purposes of establishing
quorum at such meeting all of the Ordinary Shares beneficially owned by such Holder, including the Warrant Shares (collectively, the “”), or at any adjournment thereof, and (y) vote or cause to be voted (in person, by proxy, by action by written consent,
as applicable, or as otherwise may be required or permitted under the articles of association of the Company or the terms of the
applicable Warrant) the Holder Securities in favor of any proposal presented by the Company at such meeting. In furtherance of this provision,
concurrently herewith, the Holder hereby authorizes the Company to notify the Company’s transfer agent and/or depositary that there
is a stop transfer order with respect to the Holder Securities (and that this letter agreement places limits on the voting and transfer
of such Holder Securities).

Additionally, the Company
agrees to the representations, warranties and covenants set forth on attached hereto. The Holder represents and warrants
that, as of the date hereof it is, and on each date on which it exercises the Warrants it will be, an “accredited investor”
as defined in Rule 501 of the Securities